|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lopes JP and Fonseca E: BRAF gene mutation
in the natural history of papillary thyroid carcinoma: Diagnostic
and prognostic implications. Acta Med Port. 24 Suppl 4:S855–S868.
2011.(In Portuguese).
|
|
3
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lupoli R, Cacciapuoti M, Tortora A, Barba
L, Verde N, Romano F, Vastarella M, Fonderico F, Masone S, Milone
M, et al: Clinical outcome in differentiated thyroid carcinoma and
microcarcinoma. Int J Surg. 12 Suppl 1:S148–S151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Thyroid Association (ATA)
Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid
Cancer, . Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL,
Mandel SJ, Mazzaferri EL, McIver B, Pacini F, et al: Revised
American Thyroid Association management guidelines for patients
with thyroid nodules and differentiated thyroid cancer. Thyroid.
19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji X, Lu H, Zhou Q and Luo K: LARP7
suppresses P-TEFb activity to inhibit breast cancer progression and
metastasis. Elife. 3:e029072014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng Y, Jin Z, Agarwal R, Ma K, Yang J,
Ibrahim S, Olaru AV, David S, Ashktorab H, Smoot DT, et al: LARP7
is a potential tumor suppressor gene in gastric cancer. Lab Invest.
92:1013–1019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YH, Sui YN, Yan K, Wang LS, Wang F
and Zhou JH: BRD4 promotes pancreatic ductal adenocarcinoma cell
proliferation and enhances gemcitabine resistance. Oncol Rep.
33:1699–1706. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kondo T, Asa SL and Ezzat S: Epigenetic
dysregulation in thyroid neoplasia. Endocrinol Metab Clin North Am.
37(389–400): ix2008.
|
|
11
|
Schlumberger M and Sherman SI: Approach to
the patient with advanced differentiated thyroid cancer. Eur J
Endocrinol. 166:5–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sherman SI: Targeted therapies for thyroid
tumors. Mod Pathol. 24 Suppl 2:S44–S52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kogai T and Brent GA: The sodium iodide
symporter (NIS): Regulation and approaches to targeting for cancer
therapeutics. Pharmacol Ther. 135:355–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chung JK and Cheon GJ: Radioiodine therapy
in differentiated thyroid cancer: The first targeted therapy in
oncology. Endocrinol Metab (Seoul). 29:233–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma S, Wang Q, Ma X, Wu L, Guo F, Ji H, Liu
F, Zhao Y and Qin G: FoxP3 in papillary thyroid carcinoma induces
NIS repression through activation of the TGF-β1/Smad signaling
pathway. Tumour Biol. 37:989–998. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiang C, Zhang ML, Zhao QZ, Xie QP, Yan
HC, Yu X, Wang P and Wang Y: LncRNA-SLC6A9-5:2: A potent sensitizer
in 131I-resistant papillary thyroid carcinoma with PARP-1
induction. Oncotarget. 8:22954–22967. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bayfield MA, Yang R and Maraia RJ:
Conserved and divergent features of the structure and function of
La and La-related proteins (LARPs). Biochim Biophys Acta.
1799:365–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barboric M, Lenasi T, Chen H, Johansen EB,
Guo S and Peterlin BM: 7SK snRNP/P-TEFb couples transcription
elongation with alternative splicing and is essential for
vertebrate development. Proc Natl Acad Sci USA. 106:7798–7803.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swarbreck D, Wilks C, Lamesch P, Berardini
TZ, Garcia-Hernandez M, Foerster H, Li D, Meyer T, Muller R, Ploetz
L, et al: The arabidopsis information resource (TAIR): Gene
structure and function annotation. Nucleic Acids Res. 36:(Database
Issue). D1009–D1014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bres V, Yoh SM and Jones KA: The
multi-tasking P-TEFb complex. Curr Opin Cell Biol. 20:334–340.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Williamson AJ, Doscas ME, Ye J, Heiden KB,
Xing M, Li Y, Prinz RA and Xu X: The sonic hedgehog signaling
pathway stimulates anaplastic thyroid cancer cell motility and
invasiveness by activating Akt and c-Met. Oncotarget.
7:10472–10485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu X, Ding H, Rao G, Arora S, Saclarides
CP, Esparaz J, Gattuso P, Solorzano CC and Prinz RA: Activation of
the sonic hedgehog pathway in thyroid neoplasms and its potential
role in tumor cell proliferation. Endocr Relat Cancer. 19:167–179.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heiden KB, Williamson AJ, Doscas ME, Ye J,
Wang Y, Liu D, Xing M, Prinz RA and Xu X: The sonic hedgehog
signaling pathway maintains the cancer stem cell self-renewal of
anaplastic thyroid cancer by inducing snail expression. J Clin
Endocrinol Metab. 99:E2178–E2187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rimkus TK, Carpenter RL, Qasem S, Chan M
and Lo HW: Targeting the sonic hedgehog signaling pathway: Review
of smoothened and GLI inhibitors. Cancers (Basel). 8:E222016.
View Article : Google Scholar : PubMed/NCBI
|
